Secondary Logo

Most Popular Articles

Single-Dose Pharmacokinetics and Pharmacodynamics of IPX203 in Patients With Advanced Parkinson Disease: A Comparison With Immediate-Release Carbidopa-Levodopa and With Extended-Release Carbidopa-Levodopa Capsules

Modi, Nishit B.; Mittur, Aravind; Rubens, Robert; More

Clinical Neuropharmacology. 42(1):4-8, January/February 2019.

Long-term Outcome of Adenosine A2A Receptor Antagonist on Lower Urinary Tract Symptoms in Male Parkinson Disease Patients

Kitta, Takeya; Yabe, Ichiro; Kanno, Yukiko; More

Clinical Neuropharmacology. 41(3):98-102, May/June 2018.

Long-term Safety of Rivastigmine in Parkinson Disease Dementia: An Open-Label, Randomized Study

Emre, Murat; Poewe, Werner; De Deyn, Peter Paul; More

Clinical Neuropharmacology. 37(1):9-16, January/February 2014.

Effect of Concomitant Medications on the Safety and Efficacy of Extended-Release Carbidopa-Levodopa (IPX066) in Patients With Advanced Parkinson Disease: A Post Hoc Analysis

LeWitt, Peter A.; Verhagen Metman, Leo; Rubens, Robert; More

Clinical Neuropharmacology. 41(2):47-55, March/April 2018.

Risk of Serious Extrapyramidal Symptoms in Patients With Parkinson's Disease Receiving Antidepressant Drugs: A Pharmacoepidemiologic Study Comparing Serotonin Reuptake Inhibitors and Other Antidepressant Drugs

Gony, Mireille; Lapeyre–Mestre, Maryse; Montastruc, Jean-Louis; More

Clinical Neuropharmacology. 26(3):142-145, May-June 2003.

Movement Disorders After Exposure to Antipsychotic Drugs in Patients With Depressive Disorders

Rey, María Verónica; Molina, Luis; Recinos, Byron; More

Clinical Neuropharmacology. 41(5):177-180, September/October 2018.

Baclofen in the Therapeutic of Sequele of Traumatic Brain Injury: Spasticity

Pérez-Arredondo, Adán; Cázares-Ramírez, Eduardo; Carrillo-Mora, Paul; More

Clinical Neuropharmacology. 39(6):311-319, November/December 2016.

Clostridium butyricum MIYAIRI 588 as Adjunctive Therapy for Treatment-Resistant Major Depressive Disorder: A Prospective Open-Label Trial

Miyaoka, Tsuyoshi; Kanayama, Misako; Wake, Rei; More

Clinical Neuropharmacology. 41(5):151-155, September/October 2018.

A Randomized Double-Blind Placebo-Controlled Phase III Trial of Selegiline Monotherapy for Early Parkinson Disease

Mizuno, Yoshikuni; Hattori, Nobutaka; Kondo, Tomoyoshi; More

Clinical Neuropharmacology. 40(5):201-207, September/October 2017.

CYP1A2 Genetic Polymorphism Is Associated With Treatment Remission to Antidepressant Venlafaxine in Han Chinese Population

Zhu, Yuhao; Zhang, Naixing; Ren, Decheng; More

Clinical Neuropharmacology. 42(2):32-36, March/April 2019.

Severe Depression, Suicide Attempts, and Ideation During the Use of Interferon Beta by Patients With Multiple Sclerosis

Fragoso, Yara Dadalti; Frota, Elizabeth Regina Comini; Lopes, Juarez Silva; More

Clinical Neuropharmacology. 33(6):312-316, November-December 2010.